Skip to main content
Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease
Published Web Location
http://europepmc.org/articles/PMC3642209?pdf=renderNo data is associated with this publication.
Abstract
Novel biomarkers may improve our ability to predict which patients with chronic kidney disease (CKD) are at higher risk for progressive loss of renal function. Here, we assessed the performance of urine neutrophil gelatinase-associated lipocalin (NGAL) for
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.